Jami A. Fukui, MD

Jami A. Fukui, MD

For all patient related matters: Phone: (808) 586-5854 | Fax: (808) 586-5857
This email address is being protected from spambots. You need JavaScript enabled to view it. | (808) 441-8199

Full Member, Cancer Biology, University of Hawaiʻi Cancer Center
Core Clinical Member, Translational and Clinical Research, University of Hawaiʻi Cancer Center

Academic Appointment(s):
Associate Professor (Associate Researcher), University of Hawaiʻi Cancer Center, University of Hawaiʻi at Mānoa
Assistant Professor, Department of Medicine, John A. Burns School of Medicine, University of Hawaiʻi at Mānoa

MD, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ
Internal Medicine Residency, Mount Sinai Hospital, New York, NY
Hematology/Oncology Fellowship, Mount Sinai Hospital, New York, NY


2020 Hawaiʻi's Best Physicians Patients' Choice Award, rated above national 90th percentile for an entire year
NCI Breast Cancer Steering Committee member the National Cancer Institute (NCI) Community Oncology Research Program (NCORP) representative
Southwest Oncology Group (SWOG) Supportive Oncology Committee Member

Research Focus

Dr. Fukui is an Associate Professor at the University of Hawaiʻi Cancer Center. Her interests are in breast cancer clinical and translational research, developing clinical trial protocols, and providing cancer care to residents of Hawaiʻi.

  1. Tumor microenvironment
    Characterizing the tumor microenvironment (TME) has led to novel therapies in cancer treatment. Within the TME, tumor infiltrating lymphocytes are both predictive of therapy response and prognostic in breast cancer. Evaluating these immune cells can inform clinicians and their patients of potential therapy options and overall outcomes.

  2. Racial/ethnic disparities in breast cancer treatment and outcomes
    Hawaiʻi has one of the highest incidence of breast cancer cases in the U.S. There are accompanying differences in breast cancer mortality according to racial/ethnic group. Evaluating disparities in cancer treatment and coordinating quality improvement for breast cancer care within Hawaii can be achieved through clinical trials.

  3. Lifestyle modification and symptom control in cancer survivors.
    The role of lifestyle modification for prevention of primary breast cancer, secondary cancers and recurrence is an important adjunct to cancer care. Symptom control in cancer patients and survivors can improve therapy adherence and overall quality of life. Clinical trials with patient reported outcomes are increasingly important to capture multiple aspects of patient care.

Selected Publications

Bansil S, Silva A, Taniguchi A, Wiedmer C, Fernandez M, Pagano I, Vierkoetter K, Killeen J, Fukui J. (2023). Racial/Ethnic Differences Among Tumor-Infiltrating Lymphocytes in Breast Cancer Tumors. Oncologist; Feb 8;28(2):116-122. doi: 10.1093/oncolo/oyac239. PMID: 36495151.

Modi S, Saura C, Yamashita T, Park YH, Kim S-B, Tamura K, Andre F, Iwata H, Ito Y, Tsurutani J, Sohn J, Denduluri N, Perrin C, Aogi K, Tokunaga E, Im S-A, Lee KS, Hurvitz SA, Cortes J, Lee C, Chen S, Zhang L, Shahidi J, Yver A, Krop I, DESTINY-Breast01 Investigators. (2020). Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer. N Engl J Med; Feb. 13;382(7):610-621. doi: 10.1056/NEJMoa1914510. Epub 2019 Dec 11. PMID: 31825192.

Gatti-Mays ME, Balko JM, Gameiro SR, Bear HD, Prabhkaran S, Fukui J, Disis ML, Nanda R, Gulley JL, Kalinsky K, Sater HA, Sparano JA, Cescon D, Page DB, McArthur H, Adams S, Mittendorf EA. (2019). If we build it they will come: targeting the immune response to breast cancer. NPJ Breast Cancer. Oct 29;5:37. doi: 10.1038/s41523-019-0133-7. eCollection 2019. PMID: 31700993.

Fukui J, White K, Frankland TB, Oshiro C, Wilkens L. (2021). Weight changes according to treatment in a diverse cohort of breast cancer patients. BMC Cancer; 21:1005.

Publication list via PubMed

Active Grants

J. Fukui, Co-Investigator; L. Loo and I.Cheng (PIs)
R01 CA 229815
“The Role of 27-hydroxycholestrol in Breast Cancer: A Population-Based Multiethnic Study”
03/01/19 – 02/28/24

J. Fukui, PI
NCORP Pilot Grant Award
The HOPE Foundation for Cancer Research
"Expansion of a successful intervention to increase NH/PI accrual to clinical trials in an underserved rural community on Oahu."
7/1/2022 – 6/30/2023

J. Fukui, PI
Loan Repayment Program-Health Disparities Research
08/01/2020 – 07/31/2022

J.Fukui, Co-Investigator; E. Bantum (PI)
UHCC-Strategic Initiative for Translational Science Grant
“Mobile Mindfulness for Cancer Related Neuropathy”
04/01/20 – 03/31/2022

J. Fukui, PI
University of Hawaiʻi Cancer Center Pilot Grant
“A Reader Study to Support Primary Breast Cancer Screening in the Pacific using Portable Ultrasound”
01/01/21 – 12/31/2021